These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4395081)

  • 21. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of magnesium asparaginate on the coronary circulation.
    Görög P; Ezer E; Szporny L
    Arzneimittelforschung; 1966 Nov; 16(11):1488-90. PubMed ID: 6014963
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 24. Hemodynamic effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956): a nonadrenergic myocardial stimulant.
    Osborne MW; Wenger JJ; Moe RA
    J Pharmacol Exp Ther; 1971 Jan; 176(1):174-83. PubMed ID: 4398214
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 26. [Contractility and dynamics of the heart after Oxyfedrin and propranolol].
    Stauch M; Härich BK
    Arztl Forsch; 1971 Apr; 25(4):101-9. PubMed ID: 4396526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Circulatory effects of a new specific beta adrenergic blocking agent, (o-(2-hydroxy-3-(tert. butylamino)-propoxyl)-benzonitrile, Kö 1366)].
    Gilfrich HJ; Rahn KH; Nicolescu RF
    Arzneimittelforschung; 1973 Jun; 23(6):768-71. PubMed ID: 4146902
    [No Abstract]   [Full Text] [Related]  

  • 28. Importance of intrinsic activity to action of practolol.
    Conway J; Reeves M
    Br Heart J; 1972 Sep; 34(9):963. PubMed ID: 4403882
    [No Abstract]   [Full Text] [Related]  

  • 29. [N6-(naphthyl-(1))-methyladenosine, an adenosine derivative with prolonged coronary effect].
    Jahn W
    Arzneimittelforschung; 1969 May; 19(5):701-4. PubMed ID: 5819777
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug interactions between cardiac glycosides and beta-sympathomimetics].
    Greeff K; Köhler E; Fortmüller HW; Schmidt R
    Arzneimittelforschung; 1973 Jun; 23(6):759-64. PubMed ID: 4740757
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemodynamic effects of a new beta-adrenergic blocking agent. Study of normal subjects in various cardiocirculatory functional conditions].
    Starcich R; Barbaresi F; Bacuzzi E; Valentino RV
    Minerva Cardioangiol; 1966 Nov; 14(11):650-7. PubMed ID: 5999111
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary flow and and cardiac output of waking dogs during physical exertion under beta-receptor blockade].
    Kucharczyk M; Holtz J; Stoian D; Bassenge E
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):384-5. PubMed ID: 4397504
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
    Vatner SF; McRitchie RJ; Braunwald E
    J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemodynamic and electrocardiographic effects of practolol during upright exercise in coronary heart disease.
    Rousseau MF; Brasseur LA; Detry JM
    Cardiovasc Res; 1973 May; 7(3):306-12. PubMed ID: 4146653
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemodynamic effects of a new beta-blocking agent 'Sectral' (M & B 17803A).
    Lewis BS; Bakst A; Mitha AS; Purdon K; Gotsman MS
    Br Heart J; 1973 Jul; 35(7):743-51. PubMed ID: 4146280
    [No Abstract]   [Full Text] [Related]  

  • 37. [Function of beta-receptors in the heart].
    Morgenstern C; Arnold G; Holtermann W; Loewen U; Lochner W
    Z Kreislaufforsch; 1970 Nov; 59(11):1003-16. PubMed ID: 4395820
    [No Abstract]   [Full Text] [Related]  

  • 38. Phentolamine and beta-adrenergic receptors.
    Zahir M; Gould L
    J Clin Pharmacol New Drugs; 1971; 11(3):197-203. PubMed ID: 4400713
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of urocortin II administration on the coronary circulation and cardiac function in the anaesthetized pig is nitric-oxide-dependent.
    Grossini E; Molinari C; Mary DA; Marino P; Vacca G
    Eur J Pharmacol; 2008 Jan; 578(2-3):242-8. PubMed ID: 17936748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.